PMID: 8946471Oct 1, 1996Paper

A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotype

Pharmacogenetics
T YokoiTetsuya Kamataki

Abstract

The CYP2D6 gene of a Japanese sparteine poor metabolizer (PM, proband) showing a urinary sparteine metabolic ratio of 31.6 was analysed, and a heterozygous CYP2D6(D), a deletional type, was found by restriction fragment length polymorphism analysis with Xba I enzyme. The PM did not have any other previously described mutations in the CYP2D6 gene causing the loss of catalytic activity of the CYP2D6 enzyme. Thus, a possible new allele(s) responsible for the PM phenotype was analysed. The results indicated that the PM possessed a new 9-base insertion in exon 9, designated CYP2D6(J9). The CYP2D6(J9) and CYP2D6(D) alleles were clarified to be inherited from the mother [2D6(W)/2D6(J9)] and the father [2D6(W)/2D6(D)], respectively. The 9-base insertion caused a large increase in the apparent K(m) value for bufuralol 1'-hydroxylation as examined by expression of the enzyme protein in yeast. Four of 300 Japanese carried a heterozygous CYP2D6(J9) allele (0.7%, 4/600 chromosomes) as determined by a polymerase chain reaction analysis.

Citations

Feb 26, 2010·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Patricia NeafseyBabasaheb Sonawane
Nov 2, 2011·Drug Metabolism and Pharmacokinetics·Kazuma KiyotaniHitoshi Zembutsu
Nov 2, 2011·Drug Metabolism and Pharmacokinetics·Masahiro Hiratsuka
Dec 22, 2011·Drug Metabolism and Pharmacokinetics·Lay Kek Teh, Leif Bertilsson
Oct 13, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Nov 20, 2002·Pharmacogenetics·Michihiro ChidaTetsuya Kamataki
Oct 25, 2013·International Review of Psychiatry·Andrea Gaedigk
Mar 11, 2000·Drug Metabolism Reviews·R Kato, Y Yamazoe
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Jul 6, 2010·Ageing Research Reviews·Davide SeripaAlberto Pilotto
Apr 19, 2003·British Journal of Clinical Pharmacology·Akihiro IshiguroTatsuji Iga
Sep 6, 2005·Drug Metabolism and Pharmacokinetics·Aiko EbisawaMichinao Mizugaki
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Hiroshi YamazakiTetsuya Kamataki
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Kiyoshi Nagata, Yasushi Yamazoe
Nov 8, 2003·Clinical Journal of Oncology Nursing·Kim K KueblerRonald A Mihelic
Sep 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Koichi OharaHaruo Shibuya
Mar 12, 2003·The Pharmacogenomics Journal·D NikoloffJ G Shin
Mar 30, 2007·Clinical Pharmacology and Therapeutics·A GaedigkM J Kennedy
Apr 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Su-Jun LeeJae-Gook Shin
Aug 1, 2020·The American Journal of Hospice & Palliative Care·Kayoko MorioIkuko Yano
Oct 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tomoko ShiraishiKan Chiba
Sep 12, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kanako SakuyamaMasahiro Hiratsuka
Mar 25, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tsutomu SakumaTetsuya Kamataki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.